Search bioRxiv⌕ Search

Biology subjects

Hezil, N.

Publications and source records attributed to Hezil, N..

2 recordsLinked to original sources

Cooperative Modular Representation Learning for Lung Adenocarcinoma Survival Prediction from Transcriptomic and Clinical Data

Accurate prognosis in lung adenocarcinoma (LUAD) requires integration of high-dimensional transcriptomic profiles with compact but clinically stable patient covariates. Naive fusion strategies allow the high-variance RNA-seq modality to dominate learned representations, suppressing clinical signal. We present Cooperative Modular Representation Learning (CMRL), an uncertainty-gated multimodal framework that dynamically regulates inter-modality information flow based on sample-level epistemic uncertainty estimated via Evidential Deep Learning (EDL). Each modality encoder produces a latent embedding and a scalar uncertainty score; an adaptive communication gate controls how much each module updates its representation from messages sent by the other module. A Variational Information Bottleneck (VIB) on the transcriptomic encoder further suppresses noise in the high-dimensional genomic latent space. CMRL is evaluated via 5-fold stratified cross validation on 490 TCGA-LUAD patients with matched RNA-seq (504 features) and clinical data. It achieves a concordance index (C-index) of 0.732 {+/-} 0.024, AUROC of 0.772 {+/-} 0.019, and AUPRC of 0.773 {+/-} 0.056 for 3-year survival prediction, outperforming a concatenation-fusion baseline (C-index 0.656), RNA-only (0.711), and clinical-only (0.670) variants, as well as several published LUAD survival models including CustOmics (0.625) and a whole-slide imaging method (0.675). An ablation study confirms that the uncertainty gate and evidential heads each contribute independently to the gain. Calibration analysis yields an Expected Calibration Error of 0.122, and uncertainty-stratified evaluation shows that low-uncertainty patients achieve AUROC 0.795 versus 0.681 for high-uncertainty patients, providing interpretable evidence that the gate mechanism is functioning as intended.

cancer biology↗

Discovery of a Systemic Immune-Inflammatory Axis Bridging the Neuroendocrine System and Breast Tumor Microenvironment via MMD-Regularized Cross-Tissue Latent Alignment

The breast tumor immune microenvironment (TIME) is predominantly studied as a localized phenomenon. However, emerging evidence suggests tumor immune evasion may be systemically linked to master neuroendocrine regulatory centers. Investigating this systemic axis is computationally intractable due to the impossibility of sampling paired brain and breast transcriptomes from living patients. Here we present a novel in silico framework utilizing MMD-regularized cross-tissue latent alignment to bridge unpaired transcriptomic profiles from GTEx neuroendocrine tissues and the TCGA-BRCA cohort. By projecting high-dimensional RNA-seq data into a shared topological space via a Domain Adaptation Autoencoder optimized with Maximum Mean Discrepancy ([L]MMD), we established a robust mathematical bridge across tissues. Interrogation of the aligned 128-dimensional latent space isolated a dominant systemic immune-inflammatory signature rather than canonical endocrine hormone amplification. Dimension 31 of the aligned space was anchored by T-cell receptor variable chains (TRAV35, TRAV8-4, TRBV2), immunoglobulins (IGHG1, IGHGP), and the lipid-inflammatory mediator PLA2G2D, orthogonally linking pituitary neuroinflammation to a "hot" breast TIME. Independent cross-platform validation on the METABRIC microarray cohort (n = 1,980) recovered the same underlying mechanism via latent axis rotation, capturing the systemic acute-phase secretome: PLA2G2A, LBP, SAA1, and CXCL17. These findings suggest a population-level latent correspondence between neuroendocrine inflammatory programs and breast tumor immune phenotypes, revealing candidate targets for liquid biopsy and systemic immunotherapeutic investigation that warrant prospective experimental validation.

cancer biology↗